Procter & Gamble (P&G), the US consumer goods giant, has entered into a definitive agreement to acquire Thorne, a US-based provider of personalized health and wellness solutions, from L Catterton’s Flagship Fund.
Founded in 1984, Thorne offers clinical nutritional supplements and technology tools, including its AI-powered wellness advisor Taia. The company operates a manufacturing facility in South Carolina. According to the company, the acquisition will position Thorne to expand its mission as a personalized health brand, leveraging P&G’s scale while maintaining its focus on scientific research and product quality.
Thorne CEO Colin Watts commented: “For more than 40 years, Thorne has earned the trust of healthcare practitioners, consumers, and partners by putting science, quality, and the people we serve at the center of every decision. As we looked to the future, we kept coming back to one question: What will best position Thorne to continue fulfilling its mission? We believe P&G is the right partner to help us expand our impact while staying true to the values and standards that have always defined Thorne”.
Paul Gama, CEO of P&G Health Care, stated that Thorne strengthens P&G’s position in premium wellness with a science-backed brand that complements its existing portfolio.
The deal is expected to close later this year, subject to customary closing conditions and regulatory approvals. Financial terms were not disclosed.
Source: Thorne (via PR Newswire)
